Boosting Blood Warmer Market: Rising Hypothermia Cases Drive Demand for Effective Body Temperature Management

---

Table of Content

The blood warmers market is anticipated to be worth USD 1.46 billion in 2022 and is expected to rise to USD 2.72 billion by 2032, anticipated to grow at a strong CAGR of 6.41 percent during the projection period 2023 to 2032.

One of the main factors propelling the growth of the blood warmers market is the increase in illnesses where the body temperature drops, such as hypothermia. When heat is lost from the body more quickly than it is gained, the body's temperature falls below 35°C.

Market Overview:

The danger of hypothermia is reduced by using blood warmer to warm blood or other fluids. For the maintenance of the cells, the blood is kept chilled. Hemolysis, or the disintegration of the blood cells, must also be avoided, so it is imperative to reheat it to the proper temperature. The main element promoting the use of blood warmer during the treatment of the injury is the rising number of trauma cases and surgeries around the world.

The World Health Organization (WHO) reports that between 20 and 40 million people will sustain serious injuries in June 2021, with an increase in the number of physical disabilities.  The chance of hypothermia is reduced by warming blood or other fluids with blood warmer. The cells in the blood are kept healthy by keeping it cold. Hemolysis, or the disintegration of the blood cells, must be avoided by reheating it to the proper temperature.

The rise in trauma cases around the world is the main factor influencing the increased use of blood warmers in surgery and trauma care. The number of people with physical disabilities will increase, and between 20 and 40 million people will sustain serious injuries by June 2021, predicts the World Health Organization (WHO).

The introduction of battery-operated and portable IV warmers is one technical advancement in IV warmers that has contributed to the market's revenue growth. Particularly in an emergency, these cutting-edge devices are useful, handy, and simple to use. Another factor driving the need for blood IV warmers is the growing understanding of the value of patient safety and the necessity of efficient healthcare services.

Blood Warmers Market Report Scope:

Report Highlights:

• By Products, the rising number of traffic accidents, mishaps, gunshot wounds, and other injuries is expected to fuel growth in the category. The market is anticipated to grow as a result of these and other factors, including the aging population, better financing for healthcare infrastructure in developing economies, and the rising rate of hospitalization due to various medical illnesses.   Additionally, hospital stays and surgical procedures are the primary causes of the need for IV infusions or blood transfusions. The portable blood/IV warmers market, however, is predicted to grow at a CAGR of xx% from 2022 to 2032. It is anticipated that demand for portable devices will remain slightly higher than that for non-portable devices in the upcoming years. The majority of the demand is met by the defense, rescue, and ambulatory/paramedic industries. The category is also anticipated to grow as a result of increased demand from outlying clinics and emergency rooms.
• By End Use, With a 66% revenue share in 2022, the hospitals/clinics category led the market. The demand for blood warmers has grown as surgical procedures are performed on more people worldwide. These items help surgeons keep a patient's body temperature within healthy ranges and prevent hypothermia while they are on the operating table. Because they can heat a larger volume of blood or IV solutions and are cheaper and simpler to maintain, blood-warming machines are frequently used in hospitals. Moreover, businesses are concentrating on creating hemodialysis machines that can perform a range of interventions. The end-user experience is likely to be impacted by this. Government organizations are buying blood warmers across a wide range of countries to provide effective care in an emergency, which is expected to spur sector growth soon.  For instance, in March 2021, the medical technology company MEQU received a request for portable blood warmers from the Norwegian National Air Ambulance Services.

Regional Insight:

North America dominated the market in 2022 and contributed 41% of the total revenue. The industry is growing in the area as a result of the presence of significant companies, sizeable government investments in the development of cutting-edge medical equipment, and advantageous reimbursement conditions. The US is anticipated to contribute significantly to the market's growth during the projected period. The US government allocates a sizable portion of its GDP to healthcare each year.

According to the Organization for Economic Co-operation and Development (OECD), the healthcare sector will contribute nearly % of the country's GDP in 2020. Also, compared to other industrialized nations, the United States has a higher rate of preterm births. One in ten newborns born in the US each year is preterm, according to the Centers for Disease Control and Prevention. According to the same data, six out of ten persons have one or more different types of chronic diseases.

On the other hand, over the next ten years, the CAGR for the market in Asia Pacific is expected to be the highest. The industry is expected to have a very high potential for growth due to the large patient base and the growing demand for affordable, high-tech healthcare solutions in the area. The demand for blood warmers is rising due to the area's rising rate of newborn infant deaths from hypothermia. The two main signs of hypothermia are a significant drop in body temperature and a diminished ability to produce heat. According to UNICEF, birth asphyxia, congenital abnormalities, neonatal infection, and hypothermia are the top five causes of newborn mortality in India.

Market Dynamics:

Drivers:

The market is anticipated to be dominated by the intravenous warming system segment

The incidence of unintentional perioperative hypothermia during surgical procedures can be significantly reduced by the use of intravenous warming systems. All intraoperative infusions have been advised to use blood warmer devices, which are made to deliver fluid at body temperature (37 °C). The high growth rate can be attributed to the increase in surgical procedures, which is primarily brought on by the rise in serious chronic illnesses and other conditions that have an impact on the kidneys over time.

According to the World Health Organization, 15 million babies will be born too soon in 2021, increasing the demand for blood-warming equipment in hospitals and clinics. These accidents and emergencies result in surgeries, which in turn will fuel the market for blood-heating devices. The intravenous warming system is therefore anticipated to have substantial expansion throughout the projection period as a result of the aforementioned considerations.

Restraints:

High cost of advanced blood warmer

The price of advanced blood warmer items is quite high for some environments, like home care. The cost per person is higher for low- and middle-income countries. In India, for instance, the price per piece ranges from 50,000 to 1,50,000 INR. The market for blood warmer devices may not be able to grow in some developing countries as a result of these expensive prices and low reimbursement rates. 

Additionally, strict regulations on the efficiency and safety of blood warmer devices in various countries may limit the market to some extent. For example, the USA Food and Drug Administration (FDA) discovered blood warmer devices that may be at risk of aluminum leaking in September 2021 and directed a voluntary recall action. 

Opportunities:

The incidence of hypothermia is rising

The global market is anticipated to benefit from increased awareness of the management of hypothermia in countries with low awareness. For instance, the faculty of medicine at Menoufia University in Egypt has investigated the effect of developing guidelines on nurses' performance to prevent hypothermia in preterm infants.  In developing countries, hypothermia is a major factor in neonatal deaths. In light of this, increased research, technological advancement, and public awareness would lead to an increase in the use of blood warmer devices in hospitals and clinics.  These devices help keep a person's body temperature at a normal level.

Recent Development:

• May 2022, Life Warmer launched the Quantum Blood and Fluid Warming System. The product is a revolutionary innovation that has succeeded in closing a critical ability divide previously left exposed by other commercial off-the-shelf fluid warmers currently fielded. 
• July 2021, In cooperation with the U.K. partner Fenton Pharmaceuticals, MEQU won a public tender to provide transportable blood and IV fluid warming equipment (M Warmer System) to the Ministry of Defense (MOD).  In addition, HKM Group established relationships with the military, EMS, police, hospitals, and specialty emergency providers with ease in Australia and New Zealand.

Major Key Players:

• ICU Medical
• Vyaire Medical, Inc.
• Stryker Corporation
• Estill Medical Technologies, Inc.
• The Surgical Company PTM
• Life Warmer
• MEQU
• Smisson-Cartledge Biomedical
• Gentherm Medical
• Belmont Medical
• 3M

Buy this Research Report@ https://www.precedenceresearch.com/checkout/2717

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com| +1 9197 992 333